| 1. |
Vuitton DA, Zhou H, Bresson-Hadni S, et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology, 2003, 127 Suppl:87-107.
|
| 2. |
路越晴, 鄧勇, 張靈強, 等. 泡型肝包蟲病的臨床治療進展. 中國普外基礎與臨床雜志, 2016, 23(5):547-550.
|
| 3. |
侯玉虎, 馬淑梅, 樊海寧, 等. 青海達日、班瑪地區小學生肝包蟲病患病情況調查. 現代預防醫學, 2016, 43(13):2363-2365, 2381.
|
| 4. |
張昀昊, 任利, 陽丹才讓, 等. 肝泡型包蟲病根治性切除163例回顧性分析. 中國普通外科雜志, 2016, 25(2):257-263.
|
| 5. |
劉平, 李金花, 李印, 等. 包蟲病病原在我國的流行現狀及成因分析. 中國動物檢疫, 2016, 23(1):48-51.
|
| 6. |
Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol, 2011, 25(2):195-206.
|
| 7. |
吳向未, 陳雪玲, 彭心宇, 等. Ⅰ、Ⅲ、Ⅳ型膠原在肝包蟲囊腫周圍人體纖維囊壁中的特異性分層表達. 中國人獸共患病學報, 2004, 20(10):876-879.
|
| 8. |
王俊華, 魏緒法, 張傳山, 等. Ⅰ、Ⅲ、Ⅳ膠原基因在泡球蚴感染中期小鼠肝臟中的表達及意義. 中國病原生物學雜志, 2012, 7(9):653-656.
|
| 9. |
吳曉玲, 曾維政, 蔣明德, 等. 肝纖維化的信號轉導通路. 世界華人消化雜志, 2006, 14(22):2223-2228.
|
| 10. |
楊艷宏, 蔡衛民, 金國梁, 等. 日本血吸蟲感染兔肝肌成纖維細胞的動態變化及其意義. 中華醫學雜志, 1999, 79(11):870-873.
|
| 11. |
Mattern J, Stammler G, Koomagi R, et al. Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma. Anticancer Res, 1997, 17(17):621-624.
|
| 12. |
Chauchet A, Grenouillet F, Knapp J, et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clin Infect Dis, 2014, 59(8):1095-1104.
|
| 13. |
Wang J, Gottstein B. Immunoregulation in larval Echinococcus multilocularis, infection. Parasite Immunol, 2016, 38(3):182-192.
|
| 14. |
Zhang F, Pang N, Zhu Y, et al. CCR7lo PD-1hi, CXCR5+, CD4+, T cells are positively correlated with levels of IL-21 in active and transitional cystic echinococcosis patients. BMC Infect Dis, 2015, 15(1):1-11.
|
| 15. |
張夢然, 成軍. 肝纖維化研究進展. 國際消化病雜志, 2014,34(6):374-379.
|
| 16. |
張斌. 肝纖維化的發病機理研究進展. 現代診斷與治療, 2004, 15(6):354-359.
|
| 17. |
李偉道. 診斷肝纖維化、肝硬變的新進展:血清中細胞外基質成份的測定. 中國普外基礎與臨床雜志, 1997, 4(1):37-39.
|
| 18. |
王要軍, 孫自勤. 肝竇內皮細胞與肝纖維化. 臨床肝膽病雜志, 1996, 12(3):115-117.
|
| 19. |
Ryhanen L, Stenback F, Ala-Kokko L, et al. The effect of malotilate on type Ⅲ and type Ⅳ collagen, laminin and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat. J Hepatol, 1996, 24(2):238-245.
|
| 20. |
Nakayama Y, Takahara T, Miyabayashi C, et al. Ultrastructural localization of type Ⅳcollagen and laminin in the Disse space of rat liver with carbon tetrachloride induced fibrosis. Liver, 1991, 11(5):260-271.
|
| 21. |
Murawaki Y, Ikuta Y, Koda M, et al. Comparison of serum 7S fragment of type Ⅳ collagen and serum central triple-helix of type Ⅳ collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol, 1996, 24(2):148-154.
|
| 22. |
Tsutsumi M, Takase S, Urashima S, et al. Serum markers for hepatic fibrosis in alcoholic liver disease:which is the best marker, type Ⅲ procollagen, type Ⅳ collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Alcohol Clin Exp Res, 1996, 20(9):1512-1517.
|
| 23. |
陳光文, 宋彬. 非侵入性方法評價肝纖維化. 中國普外基礎與臨床雜志, 2009, 16(5):414-417.
|
| 24. |
Macwell PR, Flisiak R. Changes in serological biomarkers of liver funchtion and connective tissue turnover in chronic hepatitis B during lamivudine therapy. Biomarkerds, 2005, 10(6):475-484.
|
| 25. |
Vuitton DA, Guerret-Stocker S, Carbillet JP, et al. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd, 1986, 72(1):97-104.
|
| 26. |
Dar FK, Alkarmi T. 泡球蚴病的免疫病理學. 國際醫學寄生蟲病雜志, 1998, 25(6):270-272.
|